FdaApplication
NDA 016042
Identifiers
- fda_app_no: NDA016042
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE LLC |
| application_type | NDA |
| approval_date | 1994-03-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DYAZIDE | HYDROCHLOROTHIAZIDE; TRIAMTERENE | 25MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| DYAZIDE | HYDROCHLOROTHIAZIDE; TRIAMTERENE | 25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
2 products